EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Complexity of Immunoglobulin A Immune Responses in Respiratory Syncytial Virus Infection

Ashley Ferrier Esposito, Diego R Hijano iD, Stephania A Cormier iD

Viruses · 23.01.2026 · 18 (2) · 150

DOI: 10.3390/v18020150 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 23.01.2026. Verfasst von Ashley Ferrier Esposito und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70802, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Immunoglobulin A, Antibodies, Viral, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, NIAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) remains a leading cause of severe lower respiratory tract disease in infants worldwide. Despite extensive study in animal models and humans, fundamental age-dependent differences in mucosal immunity continue to limit the development of durable protective strategies in early life. Compared to adults, infants mount weaker humoral responses to RSV, underscoring the urgent need for effective vaccines in this age group. Immunoglobulin A (IgA), the dominant antibody isotype at respiratory mucosal surfaces, plays a central role in limiting viral replication and disease severity during RSV infection. While IgA limits RSV severity in adults, infants fail to generate robust IgA responses. Impaired IgA responses in infancy reflect unique immune regulatory pathways that shape early-life antiviral immunity. Emerging evidence highlights a critical role for regulatory B cells (Bregs), particularly neonatal Bregs (nBregs), in suppressing antiviral responses, limiting class switch recombination, and contributing to severe RSV disease. This review summarizes current evidence on IgA regulation during RSV infection, with particular emphasis on age-specific B-cell responses and the emerging role of Bregs. Improved understanding of these mechanisms has direct implications for the rational design of vaccines and immunomodulatory strategies tailored to infants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsImmunoglobulin AAntibodies, ViralRespiratory Syncytial Virus, HumanHumansAnimalsImmunity, MucosalB-Lymphocytes, RegulatoryB-LymphocytesInfant

Stichwörter der Autor:innen

B cellsimmunoglobulin Amucosal immunityregulatory B cellsrespiratory syncytial virus

Substanzen

Immunoglobulin AAntibodies, Viral

Autor:innen und Institutionen

  • Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70802, USA.
  • Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA.
  • Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38103, USA.

ORCID-Profile: Diego R Hijano, Stephania A Cormier

Förderung

  • National Institute of Allergy and Infectious Diseases
  • NIAID

Zitieren

APA

Ferrier Esposito, A., Hijano, D. R., & Cormier, S. A. (2026). The Complexity of Immunoglobulin A Immune Responses in Respiratory Syncytial Virus Infection. Viruses, 18(2), 150. https://doi.org/10.3390/v18020150

Vancouver

Ferrier Esposito A, Hijano DR, Cormier SA. The Complexity of Immunoglobulin A Immune Responses in Respiratory Syncytial Virus Infection. Viruses. 2026;18(2):150. doi:10.3390/v18020150

BibTeX
@article{FerrierEsposito2026,
  author = {Ferrier Esposito, Ashley and Hijano, Diego R and Cormier, Stephania A},
  title = {The Complexity of Immunoglobulin A Immune Responses in Respiratory Syncytial Virus Infection},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {150},
  doi = {10.3390/v18020150}
}
Kostenlos starten →